These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 28008827)

  • 21. Functional metagenomics to decipher food-microbe-host crosstalk.
    Larraufie P; de Wouters T; Potocki-Veronese G; Blottière HM; Doré J
    Proc Nutr Soc; 2015 Feb; 74(1):1-4. PubMed ID: 25417646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Autochthonous microbiota, probiotics and prebiotics].
    Suárez JE
    Nutr Hosp; 2015 Feb; 31 Suppl 1():3-9. PubMed ID: 25659048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
    Han JL; Lin HL
    World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
    Gallo A; Passaro G; Gasbarrini A; Landolfi R; Montalto M
    World J Gastroenterol; 2016 Aug; 22(32):7186-202. PubMed ID: 27621567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbial Endocrinology: An Ongoing Personal Journey.
    Lyte M
    Adv Exp Med Biol; 2016; 874():1-24. PubMed ID: 26589212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the gut microbiota, prebiotics, and probiotics on human health and disease.
    Lin CS; Chang CJ; Lu CC; Martel J; Ojcius DM; Ko YF; Young JD; Lai HC
    Biomed J; 2014; 37(5):259-68. PubMed ID: 25179725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
    Chen WX; Ren LH; Shi RH
    World J Gastroenterol; 2014 Nov; 20(42):15657-63. PubMed ID: 25400449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omics approaches to study host-microbiota interactions.
    van Baarlen P; Kleerebezem M; Wells JM
    Curr Opin Microbiol; 2013 Jun; 16(3):270-7. PubMed ID: 23891019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies.
    Shanahan F; Quigley EM
    Gastroenterology; 2014 May; 146(6):1554-63. PubMed ID: 24486051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic effects of gut microbiota and its relationship with disease and modulation.
    Ho JT; Chan GC; Li JC
    BMC Immunol; 2015 Mar; 16():21. PubMed ID: 25896342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic modulation of microbiota-host metabolic interactions.
    Holmes E; Kinross J; Gibson GR; Burcelin R; Jia W; Pettersson S; Nicholson JK
    Sci Transl Med; 2012 Jun; 4(137):137rv6. PubMed ID: 22674556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characterization, influence and manipulation of the gastrointestinal microbiota in health and disease].
    García-Mazcorro JF; Garza-González E; Marroquín-Cardona AG; Tamayo JL
    Gastroenterol Hepatol; 2015; 38(7):445-66. PubMed ID: 25769877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
    Doré J; Multon MC; Béhier JM;
    Therapie; 2017 Feb; 72(1):21-38. PubMed ID: 28131442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
    Berg D; Clemente JC; Colombel JF
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):781-95. PubMed ID: 25665875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
    Serban DE
    Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical prebiotics, probiotics and synbiotics for allergists: how useful are they?
    Johannsen H; Prescott SL
    Clin Exp Allergy; 2009 Dec; 39(12):1801-14. PubMed ID: 20085596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection.
    Crow JR; Davis SL; Chaykosky DM; Smith TT; Smith JM
    Pharmacotherapy; 2015 Nov; 35(11):1016-25. PubMed ID: 26598094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics.
    Serban DE
    Cancer Lett; 2014 Apr; 345(2):258-70. PubMed ID: 23981580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.